Lisinopril-Angiotensin Converting Enzyme

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
-
== Function of Enzyme==
+
== Structure of Enzyme==
-
The angiotensin converting enzyme (ACE) is an enzyme that is found renin angiotensin system which is often known as RAS. RAS is a hormone system that regulates blood pressure and fluid as well as electrolyte balance. It is a zinc and chloride dependent metallopeptidase that is membrane bound. The job of the enzyme is to catalyze the conversion of angiotensin I to the physiologically active peptide angiotensin II. It does this cleaving C-terminal dipeptide on the angiotensin I. It also inactivates the hormone bradykinin (vasodepressor) by removing two C-terminal dipeptides. This enzyme is a type 1 membrane bound protein that has 28 residue C- terminal cytosolic domains as well as 22- residue hydrophobic transmembrane domains and it has 1227 residue extracellular domain. The extracellular domain has two more domains that branch off of it. Which are N- domains and C-domains. In each of these domains are two histidine residues which are used to binding zinc ligands with glutamine to make the geometry tetrahedral. Through mutational analyses and detailed kinetics it is clear that both zinc sites have activity which is considered to be catalytic.
+
This enzyme is a type 1 membrane bound protein that has 28 residue C- terminal cytosolic domains as well as 22- residue hydrophobic transmembrane domains and it has 1227 residue extracellular domain. The extracellular domain has two more isoforms of ACE, which are N- domains and C-domains. The N-domain plays a role in hematopoietic stem cell differentiation and proliferation while C-domain is mainly involved in blood pressure regulation. In each of these domains are two histidine residues which are used to binding zinc ligands with glutamine to make the geometry tetrahedral. Through mutational analyses and detailed kinetics, it is clear that both zinc sites have activity which is considered to be catalytic [1]
-
==Structure of Lisinopril==
+
== Function of Enzyme==
-
<Structure load='getfrozenstructure711ed9d6aa89b1cb734f526e2693d273.png size='350' frame='true' align='right' caption='Structure of Lisinopril' scene='Insert optional scene name here' />
+
The angiotensin converting enzyme (ACE) is an enzyme that is found renin angiotensin system which is often known as RAS. RAS is a hormone system that regulates blood pressure and fluid as well as electrolyte balance. It is a zinc and chloride dependent metallopeptidase that is membrane bound. The job of the enzyme is to catalyze the conversion of angiotensin I to the physiologically active peptide angiotensin II. It does this cleaving C-terminal (His-Leu) dipeptide on the angiotensin I. It also inactivates the hormone bradykinin (vasodepressor) by removing two C-terminal dipeptides.
-
Anything in this section will appear adjacent to the 3D structure and will be scrollable.
+
=Structure of Lisinopril=
 +
Lisinopril (S)-1-[(N^2-carboxyl-3-phenylpropyl]-L-lysyl-L-proline diyhdrate) is a drug that is used to inhibit ACE and to treat hypertension, congestive heart failure and improve survival after a heart attack. Its molecular formula is C21 H31 N3 O5.
-
</StructureSection>
 
-
The drug Lisinopril was patent in
 
-
Mechanism of Action ==
 
 +
== Mechanism of Action ==
 +
Lisinopril works by preventing the conversation of angiotensin I to angiotensin II. When there is a decrease in angiotensin II, it causes a reduction in aldosterone section and this in turn causes a decrease in sodium reabsorption within the collecting ducts as well as decrease potassium excretion. In the end by removing the negative feedback of angiotensin II, the drug can lead to an increase in serum renin activity. [2] As explained above there are two isoforms of the enzyme ACE, C- domain and N- Domain. While both of these domains play different roles the medication inhibits both domain’s activity however, the active part of this drug is the peptides derivatives that contain the C-terminal proline. {3}
==Side Effects==
==Side Effects==

Revision as of 19:13, 3 May 2019

ACE Structure

Caption

Drag the structure with the mouse to rotate

References

  1. Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
  2. Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644

Proteopedia Page Contributors and Editors (what is this?)

Haley Culwell, Alexander Berchansky, Michal Harel

Personal tools